Desheng Huangfu

Title: **Desheng Huangfu: Innovator in Pharmaceutical Compositions**

Introduction

Desheng Huangfu, hailing from Dongguan, China, is a notable inventor with a focus on pharmaceutical innovations. He has made significant contributions to the field through his research and development of dihydropyrimidine derivatives, which hold promise in the treatment of viral infections.

Latest Patents

Desheng Huangfu holds one patent titled "Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals." This invention focuses on L-tartaric acid complexes, as well as the acid addition salts and base addition salts of a specific compound known as (S)-4-(((R)-6-(2-chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl) morpholine-3-carboxylic acid, or its tautomer. The patent also pertains to the application of these compounds in developing medicaments, particularly for preventing, managing, treating, or alleviating hepatitis B virus (HBV) infections.

Career Highlights

Desheng Huangfu is currently employed at Sunshine Lake Pharma Co., Ltd., where he leverages his expertise to advance pharmaceutical research and development. His innovative approach has earned him recognition in the industry and has potential implications for drug formulation and efficacy.

Collaborations

At Sunshine Lake Pharma, Desheng collaborates with talented individuals such as Qingyun Ren and Liang Chen. Their teamwork fosters a creative environment that drives the development of novel pharmaceutical solutions.

Conclusion

Desheng Huangfu's innovative contributions to the field of pharmaceuticals demonstrate the importance of research in combating viral infections. His patented work continues to pave the way for advancements in medicament formulations, highlighting the critical role of inventors in enhancing healthcare through innovation.